Leerink Partners Downgrades AN2 Therapeutics (ANTX) to Market Perform, ‘not seeing a lot of responders but might be seeing some’

Visit StreetInsider.com at http://www.streetinsider.com/Analyst+PT+Change/Leerink+Partners+Downgrades+AN2+Therapeutics+%28ANTX%29+to+Market+Perform%2C+%27not+seeing+a+lot+of+responders+but+might+be+seeing+some%27/22760152.html for the full story.